To date, there is also very little research on the interaction of ACE2, cannabinoids, and cannabis smoke, although there is evidence that CBD decreased ACE2 expression [114], may inhibit SARS-CoV-2 replication [115] and reduced COVID-19 related inflammation [116]. The gene discussed is ACE2; the disease is COVID-19.